BioSyn
BioSyn is a fictional biotechnology corporation and rival to InGen in the Jurassic Park media franchise.
Last updated October 14, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
BioSyn, also known as Biosyn Corporation or Biosyn Genetics, is a fictional biotechnology company in the Jurassic Park media franchise. It is presented as a corporate rival to International Genetic Technologies, commonly known as InGen, the organization responsible for creating the cloned dinosaurs used in Jurassic Park. BioSyn’s defining characteristic is its willingness to pursue genetic research through aggressive commercial tactics, including industrial espionage and the attempted acquisition of proprietary dinosaur DNA. The company originates in Michael Crichton’s Jurassic Park novels. In the books, BioSyn is based in Cupertino, California, and operates as a controversial competitor in the genetics industry. Lewis Dodgson, a BioSyn employee, is involved in efforts to obtain InGen’s research and dinosaur embryos. The company sees the cloned animals primarily as potentially valuable biological assets rather than as components of a public theme-park venture. Its proposed uses include pharmaceutical experimentation, commercial exploitation, and hunting-related applications. This makes BioSyn an important institutional counterpoint to InGen: both companies treat genetic engineering as a commercial opportunity, but BioSyn is especially associated with secrecy, espionage, and the pursuit of intellectual property. BioSyn is only indirectly represented in the first Jurassic Park film. Dodgson appears, but the company he works for is not named in the film. The corporation is more visible in later franchise material, including video games and other licensed works. Its most substantial screen appearance comes in Jurassic World Dominion, where it is identified as Biosyn Genetics. By that point, the company has evolved from a rival seeking dinosaur DNA into a powerful genetic-research organization with a public-facing scientific infrastructure. In Jurassic World Dominion, Lewis Dodgson has become BioSyn’s chief executive. The company operates a large research and wildlife facility in the Dolomites of Italy, where it houses dinosaurs captured from around the world under a government arrangement. BioSyn publicly presents the facility as a controlled environment for studying and protecting the animals, while also conducting pharmaceutical and genetic research. Its staff includes geneticist Henry Wu and mathematician Ian Malcolm, who serves as an in-house philosophical and ethical adviser. Malcolm’s presence reinforces the company’s uneasy relationship with scientific responsibility: BioSyn employs people capable of recognizing the dangers of genetic manipulation, yet its leadership continues to pursue risky commercial schemes. The film reveals that Dodgson has used BioSyn to orchestrate a global agricultural crisis. The company releases genetically engineered giant locusts designed to consume crops belonging to competitors while leaving BioSyn-linked crops unaffected. It also holds Maisie Lockwood, a teenage girl whose genetic origins are considered valuable to the company’s research. These actions expose the gap between BioSyn’s institutional image and the conduct of its leadership. The plot is eventually uncovered, the locust threat is stopped, and Dodgson is killed during the collapse of the company’s facility. The corporation’s broader fate is not fully detailed, but its criminal activities are publicly exposed. BioSyn functions thematically as a critique of biotechnology companies that treat living organisms, scientific knowledge, and ecological systems as proprietary resources. It is not always portrayed as uniformly malicious: the company employs many scientists and workers who may believe they are contributing to legitimate research, and Colin Trevorrow described the organization as containing people with good intentions who are betrayed by Dodgson’s actions. Nevertheless, the franchise repeatedly associates BioSyn with secrecy, corporate rivalry, exploitation of genetic information, and the failure to place public safety above commercial goals.
History
BioSyn was created as a fictional corporate antagonist in Michael Crichton’s Jurassic Park novels. Unlike InGen, which is directly associated with the creation and operation of the dinosaur park, BioSyn is introduced as a competing genetics company interested in obtaining InGen’s discoveries. Its business practices are linked to industrial espionage, particularly through Lewis Dodgson, who seeks access to dinosaur embryos and genetic information. The company’s interest in the animals is utilitarian and commercial: dinosaur DNA could support pharmaceutical research, biological experimentation, trophy hunting, or other profitable applications. The novels position BioSyn within the biotechnology sector as an ambitious but ethically compromised competitor. Its activities reflect the franchise’s broader concern that genetic engineering can be controlled by corporations whose commercial incentives are stronger than their safety obligations. BioSyn is secretive and opportunistic, using intelligence-gathering and proprietary claims to compete rather than developing a publicly accountable scientific program. The first Jurassic Park film includes Dodgson, but does not identify his employer by name. BioSyn’s corporate identity nevertheless remained part of the wider franchise mythology and appeared in several video games and related works. This allowed the company to function as a recurring institutional rival even when it was not central to the films’ plots. By Jurassic World Dominion, the company is known as Biosyn Genetics and has become a powerful organization with a public scientific presence. It has a contract to house dinosaurs captured after the animals spread beyond the original islands. Its facility in the Italian Dolomites is presented as both a sanctuary and a research center. The company employs Henry Wu, a geneticist connected to the earlier dinosaur experiments, and Ian Malcolm, who serves as an internal philosophical voice. The arrangement gives BioSyn access to an unprecedented concentration of genetically engineered animals and enables research into their biology and possible medical applications. The company’s public image is undermined by Dodgson’s hidden agenda. BioSyn develops giant locusts that selectively attack crops grown by competitors while sparing crops associated with the company. It also captures Maisie Lockwood, whose unusual genetic history is valuable to the company’s research. These actions turn BioSyn from a merely questionable competitor into an organization implicated in ecological sabotage, unlawful detention, and dangerous genetic manipulation. The scheme is discovered by a group including Malcolm, Alan Grant, Ellie Sattler, Claire Dearing, and Owen Grady. The evidence is brought to light, the locust threat is addressed, and BioSyn’s leadership loses control of the facility. Dodgson dies while attempting to escape during the breakdown of the compound. The film does not establish a detailed post-crisis corporate history for BioSyn, leaving the organization’s ultimate legal and operational status unresolved. Across its appearances, BioSyn represents the commercialization of genetic knowledge without adequate ethical oversight. The company is not necessarily depicted as consisting only of villains; it employs scientists and workers who may regard their research as legitimate. However, the conduct of its leadership demonstrates how a scientific institution can be redirected toward corporate sabotage and exploitation. Its narrative role is therefore less that of a conventional consumer brand and more that of a fictional biotechnology institution used to examine corporate power, genetic ownership, and ecological risk.
- 2022
Biosyn Genetics becomes a major film organization
[1]Jurassic World Dominion depicts BioSyn as a large biotechnology company with a dinosaur facility in the Italian Dolomites.
- 2022
BioSyn’s global sabotage scheme is uncovered
[1]The company’s engineered locust program and treatment of Maisie Lockwood are exposed, while its chief executive Lewis Dodgson dies during the facility’s collapse.
- 1995
BioSyn remains part of the novel continuity
[1]The Lost World continues the franchise’s corporate and genetic-engineering setting, including the rivalry surrounding InGen’s dinosaur research.
- 1990
BioSyn appears in Jurassic Park
[1]Michael Crichton’s novel introduces BioSyn as InGen’s corporate competitor and associates it with industrial espionage involving dinosaur genetics.
Products and positioning
A secretive, commercially driven biotechnology rival whose scientific capabilities are undermined by industrial espionage, proprietary thinking, and unethical leadership.
Biotechnology
Dinosaur genetic research
BioSyn’s central scientific interest is the study and commercial exploitation of dinosaur DNA and living cloned dinosaurs. In the novels, the company seeks access to InGen’s genetic discoveries; in Jurassic World Dominion, it conducts research on captured animals held at its Dolomites facility. The research is associated with pharmaceutical and biological applications rather than public entertainment alone.
Wildlife containment and research · 2022
Biosyn dinosaur facility
In Jurassic World Dominion, BioSyn operates a large facility in the Italian Dolomites that houses dinosaurs collected from different locations. The site combines the functions of a preserve, laboratory, and corporate research center, allowing BioSyn to study the animals while presenting their containment as a regulated scientific and conservation activity.
Genetically engineered organism · 2022
Engineered giant locusts
BioSyn’s most significant biological weapon is a population of giant locusts designed to consume competitors’ crops while avoiding crops linked to the company. The program creates a global agricultural threat and demonstrates the danger of applying genetic engineering to commercial sabotage. The scheme is exposed and ultimately stopped.
Controversies
2022
Agricultural sabotage through engineered locusts
BioSyn secretly deploys genetically engineered locusts that target competitors’ crops, creating a worldwide food-security crisis and exposing the company to severe ethical and legal criticism.
2022
Detention and genetic exploitation of Maisie Lockwood
The company captures and holds Maisie Lockwood because of the scientific value of her genetic origins, making her a subject of unauthorized research.
Industrial espionage against InGen
In the novels, BioSyn is associated with attempts to steal InGen’s corporate secrets and dinosaur genetic material through its employee Lewis Dodgson.
Brand decisions
2022
Operate a dinosaur research and containment facilityStrategyBackground
After dinosaurs become dispersed around the world, BioSyn obtains a contract to house captured animals at its headquarters in the Italian Dolomites.
Action taken
The company consolidates dinosaurs in a controlled valley and uses the site for scientific and pharmaceutical research.
Aftermath
The facility becomes the setting for BioSyn’s misconduct and is destabilized when the company’s scheme is exposed.
2022
Develop and release selective giant locustsOtherBackground
BioSyn seeks commercial advantage in agriculture while maintaining a legitimate public image as a biotechnology organization.
Action taken
The company creates locusts engineered to consume competitors’ crops while sparing crops connected to BioSyn.
Aftermath
The scheme causes a global agricultural crisis, is investigated and exposed, and contributes to the collapse of BioSyn’s leadership.
2022
Recruit Henry Wu and Ian MalcolmStrategyBackground
BioSyn expands its scientific and advisory capabilities after becoming a major dinosaur research organization.
Action taken
The company employs geneticist Henry Wu and brings mathematician Ian Malcolm into an internal philosophical advisory role.
Aftermath
Their involvement places scientific ethics and responsibility inside the organization, but Malcolm ultimately helps reveal the company’s misconduct.
Recent events
- 2022
Biosyn Genetics makes its major film appearance in Jurassic World Dominion[1]
Other · Product launch
The company appears as a major biotechnology organization operating a dinosaur facility in Italy and led by Lewis Dodgson.
- 1990
BioSyn is established as InGen’s corporate rival in the novels[1]
Other
The Jurassic Park novel presents BioSyn as a controversial genetics company involved in industrial espionage and attempts to obtain InGen’s dinosaur research.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/biosyn · Editorial policy · How profiles are compiled